CN114886984A - Medicine for treating hyperosteogeny - Google Patents
Medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN114886984A CN114886984A CN202210388866.9A CN202210388866A CN114886984A CN 114886984 A CN114886984 A CN 114886984A CN 202210388866 A CN202210388866 A CN 202210388866A CN 114886984 A CN114886984 A CN 114886984A
- Authority
- CN
- China
- Prior art keywords
- medicine
- treating
- hyperosteogeny
- blood
- dragon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 29
- 229940079593 drug Drugs 0.000 title description 8
- 239000009136 dragon's blood Substances 0.000 claims abstract description 17
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 16
- 241001061264 Astragalus Species 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 210000004233 talus Anatomy 0.000 claims abstract description 12
- 241000218158 Clematis Species 0.000 claims abstract description 9
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 8
- 229940023019 aconite Drugs 0.000 claims abstract description 8
- 235000017008 Dioscorea nipponica Nutrition 0.000 claims abstract description 7
- 241000908494 Dioscorea nipponica Species 0.000 claims abstract description 7
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims description 7
- 241000195954 Lycopodium clavatum Species 0.000 claims description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 6
- 240000003801 Sigesbeckia orientalis Species 0.000 claims description 5
- 235000003407 Sigesbeckia orientalis Nutrition 0.000 claims description 5
- 240000002853 Nelumbo nucifera Species 0.000 claims description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 4
- 241000212322 Levisticum officinale Species 0.000 claims description 2
- 239000001645 levisticum officinale Substances 0.000 claims description 2
- 241001300193 Speranskia Species 0.000 claims 2
- 244000061520 Angelica archangelica Species 0.000 claims 1
- 241000213006 Angelica dahurica Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241000628997 Flos Species 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 13
- 238000002156 mixing Methods 0.000 description 8
- 241000227129 Aconitum Species 0.000 description 5
- 240000002045 Guettarda speciosa Species 0.000 description 5
- 244000018716 Impatiens biflora Species 0.000 description 5
- 235000015912 Impatiens biflora Nutrition 0.000 description 5
- 235000005155 Tanacetum balsamita Nutrition 0.000 description 5
- 241000928504 Centipeda minima Species 0.000 description 4
- 241000903946 Clematidis Species 0.000 description 4
- 241000112528 Ligusticum striatum Species 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000008558 Osteophyte Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 241000133134 Saussurea Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicine preparations, and provides a medicine for treating hyperosteogeny, which comprises dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, wherein the mass ratio of the dragon's blood, the astragalus, the clematis root, the dioscorea nipponica makino to the prepared aconite root is 1: 3: 7: 5: 1.5, also comprises radix Angelicae sinensis, rhizoma Ligustici Chuanxiong, Carthami flos, herba Saussureae Involueratae, herba Speranskiae Tuberculatae, herba Lycopodii, and Siegesbeckiae herba. By adopting the technical scheme, the problems of relatively poor curative effect and low cure rate of the medicine for treating the hyperosteogeny in the prior art are solved.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a medicine for treating hyperosteogeny.
Background
Hyperosteogeny refers to the formation of osteophytes in the joints or spine, commonly known as "bone spur", which is usually caused by the high mobility and heavy loads in the cervical, lumbar, sacral, knee, heel, etc. With the age, the elasticity of the articular cartilage of a human is weakened, cartilage collagen fibers are exposed, the middle part of the joint is easy to wear when moving, the peripheral cartilage surface is subjected to metabolic proliferation and hypertrophy, and finally ossification is carried out to form bone spurs. Occupational permanent exertion, long-term body position badness, chronic or mechanical stimulation, traumatic injury and the like are important causes of diseases.
The treatment methods of the hyperosteogeny comprise operation treatment, acupuncture treatment, direct current medicine iontophoresis, massage and traction, traditional Chinese medicine therapy and the like. The surgical treatment is to excise the focus through the operation, but has very strict requirements on the indication and is easy to relapse; acupuncture therapy can promote menstruation and blood circulation, diminish inflammation and relieve pain, but cannot radically cure the diseases; the direct current drug ion introduction method is that drug ions are poured in under the action of current, but the poured drug is liquid and is volatile, and the drug effect is not lasting; the massage and traction are helpful for improving local blood circulation, diminishing inflammation and relieving pain, and relieving the pressure of the bony spur on local nerves and tissues, but the pain can be only temporarily relieved, and the radical treatment can not be realized; the traditional Chinese medical treatment law is to use medicines for diseases, exerts curative effect through strong penetration of medicines, has lasting effect, is simple and easy to implement, and has no side effect, but the existing medicines for treating hyperosteogeny have relatively poor curative effect and low cure rate.
Disclosure of Invention
The invention provides a medicament for treating hyperosteogeny, which solves the problems of relatively poor curative effect and low cure rate of the medicaments for treating the hyperosteogeny in the prior art.
The technical scheme of the invention is as follows:
the medicine for treating the hyperosteogeny is characterized by comprising dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, wherein the mass ratio of the dragon's blood, the astragalus, the clematis root, the dioscorea nipponica makino to the prepared aconite root is 1: 3: 7: 5: 1.5.
as a further technical proposal, the medicine also comprises angelica, Szechuan lovage rhizome, safflower and snow lotus.
As a further technical scheme, the traditional Chinese medicine also comprises garden balsam stem, common clubmoss herb and siegesbeckia orientalis.
As a further technical scheme, the mass ratio of the angelica, the ligusticum wallichii, the safflower, the snow lotus and the dragon's blood is (1-1.5): 2: (1-1.5): (1-1.5): 1.
as a further technical scheme, the mass ratio of the garden balsam stem, the lycopodium clavatum, the siegesbeckia orientalis to the dragon's blood is 2.5: 2: 2: 1.5.
the application method of the medicine for treating hyperosteogeny comprises the following steps: spraying rice vinegar onto towel, placing into metal support, collecting 20g medicinal powder, adding equal amount of tincture of rhizoma Zingiberis recens or alcohol, igniting, and fumigating focus joint for 15-20 min.
The working principle and the beneficial effects of the invention are as follows:
1. in the invention, the medicine for treating the hyperosteogeny mainly uses clematis root and is supplemented with dragon's blood, so that the medicine has the effects of activating blood circulation to dissipate blood stasis, softening hardness and dissipating stagnation, the prepared monkshood has the effects of dredging channels and activating collaterals, and relieving pain, and the astragalus root has the effects of tonifying qi and strengthening exterior, when in use, the prepared medicine enters the body through fumigation, penetrates through the skin, directly reaches focuses through the powerful penetration effect of the medicine, improves the local blood circulation, diminishes inflammation and relieves pain, and inhibits the growth of bony spur, and the cure rate of the medicine for patients with the hyperosteogeny reaches more than 93.5 percent through clinical verification.
2. According to the invention, on the basis of dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, angelica, ligusticum wallichii, safflower and saussurea involucrate are added, so that the blood circulation is promoted and the blood stasis is removed, and the treatment effect on the hyperosteogeny is further improved.
3. In the invention, based on the dragon's blood, the astragalus, the clematis root, the yam and the prepared aconite, the garden balsam stem, the lycopodium clavatum and the siegesbeckia orientalis are added to dredge the channels and activate the collaterals, thereby further improving the treatment effect on the hyperosteogeny.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any inventive step, are intended to be within the scope of the present invention.
Example 1
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima into a leaching solution, adding 1kg of fine dragon blood powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood into coarse powder, mixing the coarse powder and the premix, uniformly mixing, drying and bagging to obtain the medicament for treating the hyperosteogeny.
Example 2
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing an extraction solution from 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima, adding 1kg of dragon's blood fine powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood, 1kg of angelica, 2kg of ligusticum wallichii, 1kg of safflower and 1.5kg of saussurea involucrata into coarse powder, mixing the coarse powder and the premix, uniformly mixing, drying and bagging to obtain the medicine for treating hyperosteogeny.
Example 3
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing extraction liquid from 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima, adding 1kg of dragon's blood fine powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood, 1.5kg of angelica, 2k g ligusticum wallichii, 1.5kg of safflower, 1kg of saussurea involucrate, 2.5kg of garden balsam stem, 2kg of lycopodium clavatum and 2kg of herba siegesbeckiae into coarse powder, mixing the coarse powder with the premix, uniformly mixing, drying and bagging to obtain the medicament for treating the hyperosteogeny.
Example 4
A medicine for treating hyperosteogeny is prepared by the following steps:
preparing leaching solution from 3kg of astragalus, 7kg of radix clematidis and 5kg of centipeda minima, adding 1kg of dragon's blood fine powder to obtain a premix, standing for 2 hours at 60 ℃, crushing 1.5kg of prepared monkshood, 2.5kg of garden balsam stem, 2kg of lycopodium clavatum and 2kg of herba siegesbeckiae into coarse powder, mixing the coarse powder and the premix, uniformly mixing, drying and bagging to obtain the medicine for treating hyperosteogeny.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent substitutions, improvements, etc. within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (5)
1. The medicine for treating the hyperosteogeny is characterized by comprising dragon's blood, astragalus, clematis root, dioscorea nipponica makino and prepared aconite root, wherein the mass ratio of the dragon's blood, the astragalus, the clematis root, the dioscorea nipponica makino to the prepared aconite root is 1: 3: 7: 5: 1.5.
2. the medicament for treating hyperosteogeny according to claim 1, further comprising Chinese angelica, chuanxiong rhizome, safflower and snow lotus.
3. The medicine for treating hyperosteogeny according to claim 1 or 2, further comprising speranskia herb, lycopodium clavatum and siegesbeckia orientalis.
4. The medicament for treating the hyperosteogeny according to claim 2, wherein the mass ratio of the angelica, the Szechuan lovage rhizome, the safflower, the snow lotus and the dragon's blood is (1-1.5): 2: (1-1.5): (1-1.5): 1.
5. the medicine for treating hyperosteogeny according to claim 3, wherein the mass ratio of said speranskia herb, lycopodium clavatum, siegesbeckia orientalis to said dragon's blood is 2.5: 2: 2: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210388866.9A CN114886984A (en) | 2022-04-13 | 2022-04-13 | Medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210388866.9A CN114886984A (en) | 2022-04-13 | 2022-04-13 | Medicine for treating hyperosteogeny |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114886984A true CN114886984A (en) | 2022-08-12 |
Family
ID=82717233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210388866.9A Pending CN114886984A (en) | 2022-04-13 | 2022-04-13 | Medicine for treating hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114886984A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148971A (en) * | 1996-09-17 | 1997-05-07 | 赵胜堂 | Medicine for hyperosteogeny |
-
2022
- 2022-04-13 CN CN202210388866.9A patent/CN114886984A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148971A (en) * | 1996-09-17 | 1997-05-07 | 赵胜堂 | Medicine for hyperosteogeny |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104288538A (en) | Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster | |
CN107397949A (en) | A kind of ointment for treating neck-shoulder pain, lumbago and leg pain and preparation method thereof | |
CN1156048A (en) | Jingyaoning medicine and its preparing method | |
CN101653565A (en) | Traditional Chinese medicament externally applying paste for treating intervertebral disc protrusion | |
WO2006059853A1 (en) | Composition having effect of moxibustion and press pellet using the same | |
CN110638987A (en) | Moxibustion medicinal moxibustion stick for dispelling cold and eliminating dampness and preparation method thereof | |
CN105477783A (en) | Traditional Chinese medicine transdermal introduction plate electrode and physiotherapy instrument for treating cervical vertebra, lumbar vertebra and joint aches | |
CN1539476A (en) | Plaster for treating bone disease | |
CN102397515A (en) | Plaster for treating rheumatic diseases | |
CN110743000A (en) | Traditional Chinese medicine composition for acupoint application wet application and preparation method and using method thereof | |
CN101249179B (en) | Medicine for external application for curing hyperosteogeny and disc herniation and method of preparing the same | |
CN101244135B (en) | Medicine label for treating rheumatism, hyperosteogeny | |
CN103893298A (en) | Chinese herbal medicine rhizoma drynariae plaster and preparation method thereof | |
CN114886984A (en) | Medicine for treating hyperosteogeny | |
CN1064245C (en) | Medicine for hyperosteogeny | |
CN114306436A (en) | A Chinese medicinal composition cataplasma for treating osteoarticular pain and preparation method thereof | |
CN101530598B (en) | Plaster used for hyperosteogeny | |
CN112121086A (en) | A Chinese medicinal tincture for transdermal therapy and its preparation method | |
CN104721040A (en) | Far infrared moxibustion plaster based on traditional Chinese medicine components | |
CN1069046C (en) | Liniment for treating bony spur | |
CN103721183B (en) | A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia | |
CN103028021A (en) | Traditional Chinese medicine for treating osteomyelitis and preparation method thereof | |
CN102349949A (en) | Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica | |
CN105560537A (en) | Pharmaceutical composition for treating osteoarthritis and preparation method thereof | |
CN107456500B (en) | Preparation method of Chinese herbal medicine moxibustion plaster for adjuvant therapy of neck, shoulder, waist and leg pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220812 |
|
RJ01 | Rejection of invention patent application after publication |